Tel:400 179 0116,17521589219

Cell, culture reagent, life science research overall service provider!

Current position:Home > Products > Cell Lines > Animal cell line > Mouese cells Line > LL/2 (LLC1) Mouse lung cancer cells (Lewis)

Products Resources产品中心

CONTACT US

Current position:Home > Products > Cell Lines > Animal cell line > Mouese cells Line > LL/2 (LLC1) Mouse lung cancer cells (Lewis)
  • LL/2 (LLC1)小鼠肺癌细胞 (Lewis)

LL/2 (LLC1) Mouse lung cancer cells (Lewis)

No.:CD0865

Price: ¥2000

specification:
1E+6 Cells Flask
amount: - +
  • LL/2 (LLC1)小鼠肺癌细胞 (Lewis)
Products Description

LL/2 (LLC1) cells are derived from the Lewis lung cancer cell line of C57BL mice, established from implantation of primary Lewis lung cancer in mouse lungs. This cell line is widely used as a metastasis model and is employed to study the mechanisms of action of cancer chemotherapy drugs. (1) Tubergenicity: High tumorigenicity in C57BL mice. (2) Antigen expression: H-2b. (3) Resistance: Resistant to 1,3-bis(2-chloroethyl)-1-nitrosourea, but sensitive to methotrexate. (4) Metastatic capability: Reported to have high tumorigenicity but weak metastasis in mice. The LL/2 (LLC1) cell line is widely used for its value in cancer research, especially in studying tumor metastasis, tumor angiogenesis, and evaluating the effectiveness of chemotherapy drugs.

Animal Species: Mouse

Tissue Source:Lewis lung cancer

Morphology:Round - lightly attached to the wall or suspended;

Culture Medium Formula:DMEM (high Sugar) Complete Medium(MD0101)

Gas phase: Air, 95%; Carbon dioxide, 5%. Temperature: 37℃. 

Freezing conditions:  90% FBS (SD0200) + 10% DMSO

Complete cryopreservation solution: No Programmed Cryopreservation Cells Solution (low Serum)(SD0001)

Declaration: The product is for scientific research purposes only.



download
Related products
×